☆ 4.7 Editorial Material

Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future Avenues

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Pharmacology & Pharmacy

Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia

Yajnavalka Banerjee et al.

Summary: Inclisiran is a novel therapy that silences PCSK9 synthesis through RNA interference, effectively reducing LDL-C levels and lowering the risk for cardiovascular events. Clinical trials have shown its safety and efficacy, with injection-site reactions being more common than in the placebo group. Further studies are needed to ensure its specificity in targeting PCSK9 without affecting other physiological mRNAs.

EXPERT OPINION ON DRUG SAFETY (2022)

添加到收藏夹

Review Urology & Nephrology

COVID-19 and the kidney: time to take a closer look

Vassilios Liakopoulos et al.

Summary: COVID-19 can lead to kidney injury, causing AKI, and even mild impairment of renal function increases the risk of infection, hospitalization, and death. Dialysis patients face a higher risk of severe COVID-19 complications, and COVID-19 may present with atypical symptoms in some patients. More research is needed to understand the exact effects of SARS-CoV-2 on the kidneys, and it remains to be proven whether vaccination programs can improve outcomes for patients with kidney disease.

INTERNATIONAL UROLOGY AND NEPHROLOGY (2022)

添加到收藏夹

Article Endocrinology & Metabolism

Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect

Dragana Nikolic et al.

Summary: The vascular benefit of liraglutide in patients with type 2 diabetes is associated with reductions in atherogenic small dense LDL, independent of glycemic control and body weight reduction.

DIABETES THERAPY (2021)

添加到收藏夹

Review Endocrinology & Metabolism

Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications

Andrey Santos et al.

Summary: This review discusses the different mechanisms contributing to the pathophysiology of COVID-19, such as viral entrance, direct viral toxicity, endothelial dysfunction, and more. It is shown that viral infection triggers an integrated stress response, causing insulin resistance and synergizing with hormonal resistance from obesity and diabetes to worsen the severity of the disease. Additionally, the potential beneficial effects of drugs used to treat insulin resistance and diabetes in COVID-19 patients are explored.

DIABETOLOGY & METABOLIC SYNDROME (2021)

添加到收藏夹

Review Endocrinology & Metabolism

COVID-19 and metabolic disease: mechanisms and clinical management

Charlotte Steenblock et al.

Summary: Up to 50% of COVID-19 fatalities are associated with metabolic and vascular disorders. COVID-19 has direct links with the metabolic and endocrine systems, increasing the risk and severity of the disease in patients with metabolic dysfunction such as obesity, hypertension, non-alcoholic fatty liver disease, and diabetes.

LANCET DIABETES & ENDOCRINOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Low HDL and high triglycerides predict COVID-19 severity

Lluis Masana et al.

Summary: The presence of atherogenic dyslipidaemia during COVID-19 infection is strongly associated with a worse prognosis. Low HDL cholesterol and high triglyceride concentrations, either before or during hospitalization, are strong predictors of a severe course of the disease. Lipid profiles can be considered as sensitive markers of inflammation in patients with COVID-19 and should be measured.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Review Endocrinology & Metabolism

The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update

Michael A. Nauck et al.

Summary: Incretin hormones GIP and GLP-1 play a significant role in insulin secretion and glucose tolerance in the gut-endocrine pancreas axis. They also have additional effects on bone remodelling, lipid storage, gastric emptying, and may provide benefits for cardiovascular complications and neurodegenerative disorders. Recent research on GIP/GLP-1 receptor co-agonists has renewed interest in the potential therapeutic applications of incretin hormones.

DIABETES OBESITY & METABOLISM (2021)

添加到收藏夹

Review Endocrinology & Metabolism

COVID-19 and Obesity: Role of Ectopic Visceral and Epicardial Adipose Tissues in Myocardial Injury

Adele Lasbleiz et al.

Summary: Obesity has been identified as a risk factor for poor prognosis in COVID-19 patients, potentially due to the role of visceral adipose tissue and ectopic fat, particularly epicardial adipose tissue, in promoting inflammatory responses and worsening outcomes. The activation of pro-inflammatory cytokines and systemic viral spread in already inflamed adipose tissue may contribute to a cytokine cascade and adverse cardiovascular events in obese individuals with COVID-19.

FRONTIERS IN ENDOCRINOLOGY (2021)

添加到收藏夹

Review Endocrinology & Metabolism

COVID-19 and diabetes mellitus: from pathophysiology to clinical management

Soo Lim et al.

Summary: Initial studies have shown that patients with diabetes mellitus have a higher risk of severe COVID-19, potentially due to hyperglycaemia affecting immune and inflammatory responses. Further investigation is needed to determine the optimal management for patients with diabetes mellitus during the ongoing pandemic.

NATURE REVIEWS ENDOCRINOLOGY (2021)

添加到收藏夹

Review Immunology

Obesity-Related Inflammation and Endothelial Dysfunction in COVID-19: Impact on Disease Severity

Andrea De Lorenzo et al.

Summary: The association between obesity and COVID-19 severity has been documented, with obese patients at higher risk of complications and mortality. Inflammation plays a central role in obesity, while metabolic alterations and chronic vascular endothelial dysfunction may contribute to worse outcomes in COVID-19 for obese individuals.

JOURNAL OF INFLAMMATION RESEARCH (2021)

添加到收藏夹

Editorial Material Endocrinology & Metabolism

COVID-19 and diabetes management: What should be considered?

Antonio Ceriello et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management

Anca Pantea Stoian et al.

METABOLIC SYNDROME AND RELATED DISORDERS (2020)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies

Alessandro Mantovani et al.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2020)

添加到收藏夹

Review Medicine, Research & Experimental

Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis

Luxiang Shang et al.

ARCHIVES OF MEDICAL RESEARCH (2020)

添加到收藏夹

Article Endocrinology & Metabolism

COVID-19 in people with diabetes: understanding the reasons for worse outcomes

Matteo Apicella et al.

LANCET DIABETES & ENDOCRINOLOGY (2020)

添加到收藏夹

Article Endocrinology & Metabolism

COVID-19 and Diabetes: A Collision and Collusion of Two Diseases

Eva L. Feldman et al.

DIABETES (2020)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

COVID-19 is, in the end, an endothelial disease

Peter Libby et al.

EUROPEAN HEART JOURNAL (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry

Giuseppe De Luca et al.

CARDIOVASCULAR DIABETOLOGY (2020)

添加到收藏夹

Review Multidisciplinary Sciences

Metabolic risk factors and risk of Covid-19: A systematic review and meta-analysis

Bahram Moazzami et al.

PLOS ONE (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms

Manfredi Rizzo et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study

Manfredi Rizzo et al.

CARDIOVASCULAR DIABETOLOGY (2016)

添加到收藏夹

Article Endocrinology & Metabolism

Should low high-density lipoprotein cholesterol (HDL-C) be treated?

Peter R. Toth et al.

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2014)

添加到收藏夹

Article Pharmacology & Pharmacy

Resistin: An Inflammatory Cytokine. Role in Cardiovascular Diseases, Diabetes and the Metabolic Syndrome

Nicola Abate et al.

CURRENT PHARMACEUTICAL DESIGN (2014)

添加到收藏夹

Article Pharmacology & Pharmacy

Prevalence of dyslipidemia and associated risk factors in Turkish adults

Fahri Bayram et al.

JOURNAL OF CLINICAL LIPIDOLOGY (2014)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important?

Dragana Nikolic et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)

添加到收藏夹

Article Endocrinology & Metabolism

Ethnic differences in serum lipoproteins and their determinants in South African women

Julia H. Goedecke et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2010)

添加到收藏夹

Review Medicine, General & Internal

Cytokine Biomarkers, Endothelial Inflammation, and Atherosclerosis in the Metabolic Syndrome: Emerging Concepts

Ali A. Rizvi

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2009)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naive patients with early rheumatoid arthritis

Manfredi Rizzo et al.

ATHEROSCLEROSIS (2009)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease

Manfredi Rizzo et al.

ATHEROSCLEROSIS (2008)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study

Egle Corrado et al.

CORONARY ARTERY DISEASE (2008)

添加到收藏夹

Article Endocrinology & Metabolism

Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes

M. Rizzo et al.

DIABETIC MEDICINE (2008)

添加到收藏夹

Review Pharmacology & Pharmacy

Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes

Kaspar Berneis et al.

EXPERT OPINION ON PHARMACOTHERAPY (2008)

添加到收藏夹

Review Medicine, General & Internal

Who needs to care about small, dense low-density lipoproteins?

M. Rizzo et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2007)

添加到收藏夹

Review Peripheral Vascular Disease

Lipid triad or atherogenic lipoprotein phenotype: A role in cardiovascular prevention?

M Rizzo et al.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.